Last Updated: May 10, 2026

List of Excipients in API rilzabrutinib

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing rilzabrutinib

Subscribe to access the full database, or Start Trial
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Genzyme Corporation	WAYRILZ	rilzabrutinib	58468-0251	CELLULOSE, MICROCRYSTALLINE	2030-08-29
Genzyme Corporation	WAYRILZ	rilzabrutinib	58468-0251	CROSPOVIDONE	2030-08-29
Genzyme Corporation	WAYRILZ	rilzabrutinib	58468-0251	FD&C YELLOW NO. 6	2030-08-29
Genzyme Corporation	WAYRILZ	rilzabrutinib	58468-0251	POLYETHYLENE GLYCOL	2030-08-29
Genzyme Corporation	WAYRILZ	rilzabrutinib	58468-0251	POLYVINYL ALCOHOL	2030-08-29
Genzyme Corporation	WAYRILZ	rilzabrutinib	58468-0251	SODIUM STEARYL FUMARATE	2030-08-29
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for rilzabrutinib

Excipient focus: CELLULOSE, MICROCRYSTALLINE

rilzabrutinib drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Genzyme Corporation	rilzabrutinib	58468-0251
>Company	>Ingredient	>NDC

rilzabrutinib drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSPOVIDONE

rilzabrutinib drug variants containing CROSPOVIDONE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Genzyme Corporation	rilzabrutinib	58468-0251
>Company	>Ingredient	>NDC

rilzabrutinib drug variants not containing CROSPOVIDONE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FD&C YELLOW NO. 6

rilzabrutinib drug variants containing FD&C YELLOW NO. 6

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Genzyme Corporation	rilzabrutinib	58468-0251
>Company	>Ingredient	>NDC

rilzabrutinib drug variants not containing FD&C YELLOW NO. 6

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL

rilzabrutinib drug variants containing POLYETHYLENE GLYCOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Genzyme Corporation	rilzabrutinib	58468-0251
>Company	>Ingredient	>NDC

rilzabrutinib drug variants not containing POLYETHYLENE GLYCOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYVINYL ALCOHOL

rilzabrutinib drug variants containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Genzyme Corporation	rilzabrutinib	58468-0251
>Company	>Ingredient	>NDC

rilzabrutinib drug variants not containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STEARYL FUMARATE

rilzabrutinib drug variants containing SODIUM STEARYL FUMARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Genzyme Corporation	rilzabrutinib	58468-0251
>Company	>Ingredient	>NDC

rilzabrutinib drug variants not containing SODIUM STEARYL FUMARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TALC

rilzabrutinib drug variants containing TALC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Genzyme Corporation	rilzabrutinib	58468-0251
>Company	>Ingredient	>NDC

rilzabrutinib drug variants not containing TALC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

rilzabrutinib drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Genzyme Corporation	rilzabrutinib	58468-0251
>Company	>Ingredient	>NDC

rilzabrutinib drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.